Stocks / NASDAQ / Axsome Therapeutics, Inc.

Axsome Therapeutics, Inc.

Our Opinion

Axsome Therapeutics, Inc. is on the Cruelty Free Investing use of animals list because they exploit animals for product testing.

Some news items:

Axsome Therapeutics Announces Publication Of Research Showing AXS-02 Inhibits Pain In Animal Model Of Complex Regional Pain Syndrome. The company examined the effect of oral zoledronate on pain behavior in the rat tibia fracture model of CRPS – Globe Newswire.


Company Description

Axsome Therapeutics, Inc., a clinical stage biopharmaceutical company, develops therapies for the management and treatment of central nervous system disorders.